Afghanistan vs Sur: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Sur
62.0%
in 2024
Afghanistan rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Sur
How they compare
Afghanistan currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Afghanistan's figure about 1.6 times Sur's.
The two have swapped places 4 times across 12 shared years of data; in 2012 it was Afghanistan ahead.
Afghanistan ranks 1st and Sur ranks 2nd of 180 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Sur in 1.
Head to head by decade
| Decade | Afghanistan | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.5% | 59.6% | 14.2% | Sur |
| 2020s | 89.0% | 78.0% | 11.0% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Sur?
- Afghanistan, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Sur?
- 38.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Sur?
- 12 years are reported by both, from 2012 to 2024.
- How do Afghanistan and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.